DRMA
Price
$5.58
Change
-$0.33 (-5.58%)
Updated
Sep 17, 04:54 PM (EDT)
Capitalization
4.02M
IRON
Price
$61.03
Change
+$0.69 (+1.14%)
Updated
Sep 17 closing price
Capitalization
2.1B
49 days until earnings call
Interact to see
Advertisement

DRMA vs IRON

Header iconDRMA vs IRON Comparison
Open Charts DRMA vs IRONBanner chart's image
Dermata Therapeutics
Price$5.58
Change-$0.33 (-5.58%)
Volume$300
Capitalization4.02M
Disc Medicine
Price$61.03
Change+$0.69 (+1.14%)
Volume$418.25K
Capitalization2.1B
DRMA vs IRON Comparison Chart in %
Loading...
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRMA vs. IRON commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRMA is a StrongBuy and IRON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (DRMA: $5.58 vs. IRON: $61.03)
Brand notoriety: DRMA and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRMA: 260% vs. IRON: 124%
Market capitalization -- DRMA: $4.02M vs. IRON: $2.1B
DRMA [@Biotechnology] is valued at $4.02M. IRON’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRMA’s FA Score shows that 1 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • DRMA’s FA Score: 1 green, 4 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, both DRMA and IRON are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRMA’s TA Score shows that 3 TA indicator(s) are bullish while IRON’s TA Score has 3 bullish TA indicator(s).

  • DRMA’s TA Score: 3 bullish, 3 bearish.
  • IRON’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both DRMA and IRON are a good buy in the short-term.

Price Growth

DRMA (@Biotechnology) experienced а +1.45% price change this week, while IRON (@Biotechnology) price change was +1.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.1B) has a higher market cap than DRMA($4.03M). IRON YTD gains are higher at: -3.730 vs. DRMA (-58.667). DRMA has higher annual earnings (EBITDA): -10.54M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. DRMA (6.48M). DRMA has less debt than IRON: DRMA (175K) vs IRON (30.9M). DRMA (0) and IRON (0) have equivalent revenues.
DRMAIRONDRMA / IRON
Capitalization4.03M2.1B0%
EBITDA-10.54M-142.42M7%
Gain YTD-58.667-3.7301,573%
P/E Ratio0.28N/A-
Revenue00-
Total Cash6.48M650M1%
Total Debt175K30.9M1%
TECHNICAL ANALYSIS
Technical Analysis
DRMAIRON
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNTX0.880.03
+3.21%
Context Therapeutics
FHN22.660.39
+1.75%
First Horizon Corp
APDN2.930.05
+1.74%
Applied DNA Sciences Inc
ARQT17.150.18
+1.06%
Arcutis Biotherapeutics
PRTA8.06-0.10
-1.23%
Prothena Corp

DRMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRMA has been loosely correlated with IRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DRMA jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRMA
1D Price
Change %
DRMA100%
-5.50%
IRON - DRMA
43%
Loosely correlated
+1.15%
PVLA - DRMA
40%
Loosely correlated
+3.78%
NUVL - DRMA
30%
Poorly correlated
+0.40%
KRRO - DRMA
28%
Poorly correlated
-2.44%
KALA - DRMA
26%
Poorly correlated
-4.69%
More